康希诺生物2024年中期报告

02 04 05 22 30 31 32 35 67 2024223Xuefeng YU202422320242212024223Shou Bai CHAO20242232024221 Xuefeng YUShou Bai CHAO2024221Dongxu QIU2024221 202422320245302024627Xuefeng YU2024221 2024221202453020246272024221 20242212024221 202422120242212024221 Xuefeng YU 2024223202422320242212024221 (FCG HKFCG (PE)) •8835 185401–420 6185688185 33191901 www.cansinotech.com H 183171712–1716 1526 77334 2024 3(i)®®®Ad5-EBOVmRNAPBPV(ii)®®PCV13iTdcpDTcP(iii)HibCS-2606 mRNACS-2201CS-2028CS-2023 • ®® ®MCV4®® ®MCV2 ®202112MCV4®MPSV4®3347® ®20216 ®®30262.718.0% 46MCV4202446MCV4MCV41859 ®®®XBB.1.5 ®5SCOVID-19 ®®®®®®®®® 2024630® 20229®®202312XBB.1.5XBB.1.5 Ad5-EBOV Ad5-EBOV50%201710Ad5-EBOVAd5-EBOVGMP Ad5-EBOV(i)2˚C8˚C12(ii)(iii) Ad5-EBOVAd5-EBOV • PCV13i PCV13iPCV13PCV13i 20241PCV13iIIIPCV13i 2PCV13i 2025PCV13i PBPV PBPV23(PPV23)13(PCV13)2390PBPVAPspAPBPVPPV23PCV13 20244PBPVIIaIbIaIbPBPVIPBPV DTcP DTcP(DTaP)DTcPDTcPTdcpCS-2201 20238DTcPIII DTcPIII2025(pre-NDA) Tdcp Tdcp6TdcpTdcpBoostrixAdacel DTcPTdcp 20236Tdcp6 TdcpII2024 2023718 202312I20243IIIIII Ad5Ag85AIaI 2021Ib 2024 20237Barinthus Biotherapeutics (UK) LimitedVaccitech (UK) LimitedShingrixShingrix 202311II 2024II 202310••2 20241I 2024II Hib 52295%bHibHib 20244Hib Hib2024HibI mRNA mRNA • mRNA mRNACMC (Chemistry, Manufacturing and Controls)mRNAmRNA 20247(NIBM)mRNAmRNA ®®mRNAmRNA A ®MCV4MCV ®® 2024630285.4202363021.1COVID-19CDMO22.6 2024630187.22023630776.5COVID-19COVID-19COVID-19COVID-19CDMO 202363093.942.4%202463054.1(i)25.1(ii)22.37.5 2023630128.82024630112.5 2023630140.137.3%202463087.8 2023630338.445.1%2024630185.9IIICOVID-19 – 202363059.164.0%202463021.321.5 20246301.020236301.2 202312312,838.320246302,466.5 20231231111.82024630150.1III 20231231350.72024630359.6(i)202312311,081.52024630812.0(ii)20231231730.82024630452.4 20231231636.92024630578.1COVID-19 20231231297.52024630242.531.224.5 20231231104.0202463077.8 20231231858.335.6%2024630553.2(i)141.4(ii)115.1(iii)17.8(iv)16.3(v)14.0 20246301.12023123126.2COVID-19 20231231112.8202463057.4 202312312,047.015.9%20246301,722.2 20246304,538.4202312315,180.81,722.21,548.91,267.3 20246301,907.5202312312,591.81,185.0553.2169.3 20246301,185.0202312311,394.9990.9202312311,065.72024630536.620236 301,036.7202463025 2024630885.0657.0487.05%20246302.29%3.25%14183 2,244.7718.9 202433ª Vara Civel de Maringa/PRBelcher Farmaceutica Ltda.Belcher2021COVID-19167220 BelcherBelcher2024630 2024630219.820231231317.930.9% 20246302024630162.920231231166.9 202463020231231 2024630 (i)(ii) 3100%2024630 20242220242212 C.2.1Yu(i)(ii)Yu(iii) 2024221Dongxu QIU20242212024221(i)(ii)(iii) 2024221 2024223(i) Xuefeng YU(ii) Shou Bai CHAO(iii)(iv) 2024223 2024530 20246272023 13.51 2024630 • •2410 2023630 2024630XV352 (1)(L) –(2)2024630(3)(4)ChaoMaoChaoMao 2024630352 20246 30336 (1)(L) –(2)2024630(3)(4)2024724Mao6,000,000HChampden LLC20247242024725(5)1.40%1.33%0.49%A 2024630336 HA H H1,309.81,122.3HA20208212020630H682.82020109202212220221130H100DTcPDTcP20221221H2022125 2024630HHAH A 2020813AA4,979.5A2021429A2021528A2021512 A2024630 (1)2021429II20215282,244.7(i)AII550.0(ii)A550.0(iii)2021512A202482920262024829A (2)2023328A150.0DTcP-Hib30302023630202368A202482920252024829A (3)A(i)1,000.0A(ii)3,979.5AA (4)20201092021101120221221A3,429.5A HA 2022123150300A446.78A2022683,748A150.2152,0002024630277,650A2023 2024630 2024621YuChao2024621H 202463090,600H1,714,01820248290.04% Xuefeng YU 2024829 31662024630343434 2410 34 • 2024829 1. Xuefeng YuDongxu QiuHelen Huihua Mao20091131854401–42020172102017213 H2019328A2020813A 1A. 49.8%49.0%1.2%20242 212 2. 34 3. 202463020231231 202411 16152020177 4. 1A20231231 5. 5. 20246301,266,000202312313,567,000 6. 5 202463020231231 7. 8. 11. 11. 25% 201611 24201911 28202212 193202463015%202363015% [2023]376202463015%202363025% [2022]13202220241325%20%[2023]1220232027125%20% 12. 1A202422 2024112024131 12. 2024131 12. 13. (a) 20242023630 (b) 202320242023630 14. 6302023630 15. 206,788,0002023630233,761,0005,000202363036,0005,000202363015,000 20246 30162,879,00020231231166,890,000 2,237,00020236304,109,0003.0%20236303.1% 16. 202023630211,070,0002023630889,0001,070,0002023630878,000 202463020231231 17. 2,788,00020236304,734,00062,441,00020236301,107,000 18. 18. 18. (a) 2,952,861,000202312312,596,168,000634,073,00020231231358,445,00095,176,0002023123153,837,0002,318,788,000202312312,237,723,000 1,500,052,00020231 23 11,860,759,000775,776,000202312311,244,644,000116,502,00020231231204,862,000724,276,00020231231616,115,000 18. (b) 20. (a)1A202463071,978,000 (b)202463015,847,0002023123140,926,000(c)202463020231231 20242 274,100,00029,442,000PT Etana Biotechnologies Indonesia1.025% 23. 202363020236302023277,65016,984,00043,996,00024 24. 2018 2018528201820182023 20236303,151,36056,600,000 2023 20233272023A2023202342020232023 202